It is widely established that M1 macrophages enhance melanoma patient prognosis under their roles in inflammation promotion and tumor suppression, underpinned by the secretion of proinflammatory cytokines like IL-12 and TNF-α, alongside robust expression of nitric oxide synthase (iNOS)67,68. This evidence concerns the gene TNF and melanoma.